Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab
NCT02414984
·
clinicaltrials.gov ↗
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class
Stopped
Insufficient enrollment (Terminated due to lack of patient recruitment)
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
Golimumab
Sponsor
Janssen-Cilag, S.A.